Biological Biosurgical

Vistaseal

Payments companies reported to CMS as associated with Vistaseal. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.2Massociated payments (2023-2025)

8,804clinicians with associated payments

5companies reporting

By year

2023 $518K

2024 $605K

2025 $1.1M

Payments reported as associated with Vistaseal, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $443K

Surgery $359K

Physician Assistant $336K

Surgical $143K

Neurological Surgery $125K

Orthopaedic Surgery $123K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vistaseal

These are the largest totals companies reported as associated with Vistaseal. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Grayson Wheatley	Nashville, TN	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$263,249.24
Stephen Ingram	Austin, TX	Physician Assistant	$182,959.57
Jeanine Gargiulo	Alexandria, VA	Surgical	$78,861.58
Jonathan Black	Miramar, FL	Gynecologic Oncology	$60,282.47
Lindsey Ross	Los Angeles, CA	Neurological Surgery	$59,037.84
Andrew Nunn	Winston Salem, NC	Surgical Critical Care	$58,120.88
Richard Nguyen	Los Gatos, CA	Surgery	$54,660.09
Matthew Varacallo	Du Bois, PA	Sports Medicine (Orthopaedic Surgery)	$46,913.60
Bob Kiaii	Sacramento, CA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$40,604.15
Gitonga Munene	Kalamazoo, MI	Surgical Oncology	$37,694.94

Prescribed Vistaseal?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.